D. J. Pennell Et Al. , "Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine," AMERICAN JOURNAL OF HEMATOLOGY , vol.90, no.2, pp.91-96, 2015
Pennell, D. J. Et Al. 2015. Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. AMERICAN JOURNAL OF HEMATOLOGY , vol.90, no.2 , 91-96.
Pennell, D. J., Porter, J. B., Piga, A., Lai, Y., El-Beshlawy, A., Elalfy, M., ... Yesilipek, A.(2015). Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine. AMERICAN JOURNAL OF HEMATOLOGY , vol.90, no.2, 91-96.
Pennell, Dudley Et Al. "Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine," AMERICAN JOURNAL OF HEMATOLOGY , vol.90, no.2, 91-96, 2015
Pennell, Dudley J. Et Al. "Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine." AMERICAN JOURNAL OF HEMATOLOGY , vol.90, no.2, pp.91-96, 2015
Pennell, D. J. Et Al. (2015) . "Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine." AMERICAN JOURNAL OF HEMATOLOGY , vol.90, no.2, pp.91-96.
@article{article, author={Dudley J. Pennell Et Al. }, title={Sustained improvements in myocardial T2*over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamine}, journal={AMERICAN JOURNAL OF HEMATOLOGY}, year=2015, pages={91-96} }